-
China plans to blacklist drugmakers for bribery; violators will be suspendedIf China's pharma corruption probe hasn't spooked drugmakers enough, a new promise of punishment might. Chinese authorities say they will blacklist drugmakers caught bribing doctors and other health a2014/1/3
-
China suspends imports of Pfizer's AIDS-related drug on a paperwork problemForeign drugmakers have had their fair share of struggles inChinathis year as the country looked to cut down on healthcare spending and root outbribery. But neither of those factors caused a Tuesday h2014/1/2
-
Merck is cutting 150 in its Saphris sales team after selling the drug to Forest for $240MMerck ($MRK) early in December agreed to sell the rights to itsantipsychoticdrug Saphris to Forest Laboratories ($FRX) for $240 million. The move not only gave it a small cash boost, but it turns out2014/1/2
-
CFDA Minister Zhang Yong meets Minister of Food and Drug Safety of the Republic of KoreaOn December 19, 2013, Zhang Yong, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Chung Seung, Minister of Food and Drug Safety of the Republic of Korea. Both sid2013/12/31
-
FDA says nada to Lemtrada; will Sanofi be willing to invest in additional trials?Sanofi ($SNY) intends to appeal the FDA's denial ofLemtrada, itsmultiple sclerosisdrug that was a key reason it paid $20.1 billion to buy Genzyme two years ago. But the question burning in the mind of2013/12/31
-
Aptalis files IPO after owner TPG Capital couldn't find a buyerPrivate investment firms buy up drug companies with the idea of cashing out at some point with a big profit.TPG Capital, unable to find a buyer willing to pay its $3 billion-plus asking price forAptal2013/12/30
-
German Merck is among the companies fishing in Iran for more businessPharmaceuticals are among the small number of products that Western companies can still sell to Iran under the sanctions program designed to deter its nuclear ambitions. The process, however, is compl2013/12/30
-
GSK obtains European approval for Cervarix two-dose scheduleGlaxoSmithKline (GSK) has received marketing authorisation from the European Commission for its cervical cancer vaccine Cervarix as a two-dose schedule for girls aged nine to 14 years. Cervarix [Huma2013/12/27
-
Roche's rheumatoid arthritis drug RoACTEMRA gets CHMP positive opinionRoche has received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its subcutaneous formulation of RoACTEMRA (tocilizumab) to treat mode2013/12/27
-
PHEXCOM has sponsored and joined in the celebration for the elderly people in GuangQi Nursing House together with over 80 volunteers on 21th Dec, 2013Currently around 100 elderly people lived in Guangqi Nursing House and they are aged from 70 years old to 101 years old. Basically 3-4 people are living in one room. Most of them have religions of Cat2013/12/26